Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Uterine Cervical Dysplasia × Vaccines, Synthetic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 10 Condylomata Acuminata 10 Papillomavirus Infections 5 Vulvar Neoplasms 3 Vaginal Neoplasms 3 Uterine Cervical Dysplasia 1 Penile Neoplasms 1 Neoplasms 1 Cancer Survivor 1 Anus Neoplasms 1

Interventions

Colposcopy 17 Imiquimod 12 Conization 11 Papillomavirus Vaccines 9 Vaccines 7 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 7 Cryotherapy 7 Biopsy 6 Vaginal Smears 5 human papillomavirus vaccine, L1 type 16, 18 4 Papanicolaou Test 4 Human Papillomavirus DNA Tests 4 GX-188 vaccine 4 Acetic Acid 4 Watchful Waiting 3 Surveys and Questionnaires 3 Cisplatin 3 Blood Specimen Collection 3 VGX-3100 2 Topotecan 2 Spectrometry, Fluorescence 2 Restraint, Physical 2 Polymerase Chain Reaction 2 Paclitaxel 2 Mass Screening 2 Indomethacin 2 Immunohistochemistry 2 Human Papillomavirus Recombinant Vaccine nonavalent 2 High-Throughput Screening Assays 2 Fluorouracil 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03493542 2024-12-31

V501-213

Merck Sharp & Dohme LLC

Phase 3 Completed

766 enrolled 38 charts

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡